Skip to content

Screening of Patients With Rheumatoid Arthritis for Interstitial Lung Disease

Screening of Patients With Rheumatoid Arthritis for Interstitial Lung Disease With Radiographic and Labor Methods

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05391100
Enrollment
500
Registered
2022-05-25
Start date
2022-02-01
Completion date
2026-12-31
Last updated
2022-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial Lung Disease, Rheumatoid Arthritis

Keywords

rheumatoid arthritis, Interstitial Lung Disease

Brief summary

The quantitative and qualitative analysis of RA lung involvement in the Hungarian population

Detailed description

Interstitial lung disease (ILD) accounts for a significant proportion of mortality and morbidity in rheumatoid arthritis (RA). The aim of this prospective longitudinal study is to asess the interstitial lung involvement in Hungarian rheumatoid arthritis patients. Laboratory markers, X-ray based imaging methods, pulmonological functional tests, QOL questionnaire and sleep quality assessement questionnaire are used to estimate the interstitial lung disease. Also smaller cross-sectional studies about the imaging parameters and a national register is planned to be created based on these data.

Interventions

None listed

Sponsors

Medical Imaging Centre- Semmelweis University, Faculty of Medicine
CollaboratorUNKNOWN
Department of Pulmonology, Semmelweis University Faculty of Medicine
CollaboratorUNKNOWN
Polyclinic of the Hospitaller Brothers of St. John of God, Budapest
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosis of RA

Exclusion criteria

* pregnancy, breastfeeding * previous diagnosis of ILD, lung cancer, registered lung infection in the last 2 months

Design outcomes

Primary

MeasureTime frameDescription
pattern of ILDFrom baseline to at least 5 yearsto characterize the ILD patterns based on imaging methods
Prevalence of ILDFrom baseline to at least 5 yearsdetection of ILD with imaging methods

Secondary

MeasureTime frameDescription
Correlation with biomarkersFrom baseline to at least 2 yearscorrelation of the imaging results with respiratory function, disease activity and laboratory markers

Countries

Hungary

Contacts

Primary ContactKinga Fritsch, MD
kflinta@hotmail.com+36302892319
Backup ContactJudit Majnik, MD PhD
judit@majnik.hu+36306637976

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026